URL has been copied successfully!
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Friday.
Shares of Zenas Biopharma Inc (NASDAQ:ZBIO) fell sharply in pre-market trading. Zenas BioPharma announced pricing of concurrent public offerings of 2.50% convertible senior notes due 2032 and common stock with aggregate gross proceeds of $300.0 million.
Zenas Biopharma shares dipped 9.5% to $20.05 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
- Daqo New Energy Corp (NYSE:DQ) fell 20% to $17.00 in pre-market trading. Daqo New Energy reported mixed quarterly results on …
This post was originally published here



